These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 28161460)

  • 1. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
    Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
    J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
    BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
    Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
    BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of antiretroviral therapy initiation in adults with HIV-associated tuberculosis: outcomes of therapy in an urban hospital in KwaZulu-Natal.
    Kendon MA; Knight S; Ross A; Giddy J
    S Afr Med J; 2012 Sep; 102(12):931-5. PubMed ID: 23498040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
    Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
    HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.
    Varma JK; Nateniyom S; Akksilp S; Mankatittham W; Sirinak C; Sattayawuthipong W; Burapat C; Kittikraisak W; Monkongdee P; Cain KP; Wells CD; Tappero JW
    BMC Infect Dis; 2009 Apr; 9():42. PubMed ID: 19364398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
    Muyaya LM; Young T; Loveday M
    Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis.
    Mugusi FM; Mehta S; Villamor E; Urassa W; Saathoff E; Bosch RJ; Fawzi WW
    BMC Public Health; 2009 Nov; 9():409. PubMed ID: 19909501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
    Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
    Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
    Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
    Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
    Chem ED; Van Hout MC; Hope V
    BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.
    Abay SM; Deribe K; Reda AA; Biadgilign S; Datiko D; Assefa T; Todd M; Deribew A
    J Int Assoc Provid AIDS Care; 2015; 14(6):560-70. PubMed ID: 26289343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
    Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
    AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
    Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
    Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.
    Marcy O; Tejiokem M; Msellati P; Truong Huu K; Do Chau V; Tran Ngoc D; Nacro B; Ateba-Ndongo F; Tetang-Ndiang S; Ung V; Dim B; Neou L; Berteloot L; Borand L; Delacourt C; Blanche S;
    Lancet HIV; 2018 Feb; 5(2):e87-e95. PubMed ID: 29174612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.